BMJ, doi: 10.1136/bmj.39525.579063.BE, (Published 16 April 2008)

Research

Impact of rapid screening tests on acquisition of meticillin resistant Staphylococcus aureus: cluster randomised crossover trial

¹ Department of Infection, Guys and St Thomas’ NHS Foundation Trust, London, ² Department of Infectious Diseases, King’s College London School of Medicine, ³ Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London

Objective To determine whether introducing a rapid test for meticillin resistant Staphylococcus aureus (MRSA) screening leads to a reduction in MRSA acquisition on hospital general wards.

Design Cluster randomised crossover trial.

Setting Medical, surgical, elderly care, and oncology wards of a London teaching hospital on two sites.

Main outcome measure MRSA acquisition rate (proportion of patients negative for MRSA who became MRSA positive).

Participants All patients admitted to the study wards who were MRSA negative on admission and screened for MRSA on discharge.

Intervention Rapid polymerase chain reaction based screening test for MRSA compared with conventional culture.

Results Of 9608 patients admitted to study wards, 8374 met entry criteria and 6888 had full data (82.3%); 3335 in the control arm and 3553 in the rapid test arm. The overall MRSA carriage rate on admission was 6.7%. Rapid tests led to a reduction in median reporting time from admission, from 46 to 22 hours (P<0.001). Rapid testing also reduced the number of inappropriate pre-emptive isolation days between the control and intervention arms (399 v 277, P<0.001). This was not seen in other measurements of resource use. MRSA was acquired by 108 (3.2%) patients in the control arm and 99 (2.8%) in the intervention arm. When predefined confounding factors were taken into account the adjusted odds ratio was 0.91 (95% confidence interval 0.61 to 1.234). Rates of MRSA transmission, wound infection, and bacteraemia were not statistically different between the two arms.

Conclusion A rapid test for MRSA led to the quick receipt of results and had an impact on bed usage. No evidence was found of a significant reduction in MRSA acquisition and on these data it is unlikely that the increased costs of rapid tests can be justified compared with alternative control measures against MRSA.

Trial registration Clinical controlled trials ISRCTN75590122 [controlled-trials.com] .

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Preventing infections from cannulas reduces MRSA

Mark Melzer, Lindsey Bain, and Yasmin J Drabu
BMJ 2008 336: 1085-1086. [Extract] [Full Text] [PDF]

Screening for MRSA

Mark H Wilcox
BMJ 2008 336: 899-900. [Extract] [Full Text] [PDF]

This article has been cited by other articles:

• Harbarth, S., Samore, M. H. (2008). Interventions to control MRSA: high time for time-series analysis?. J Antimicrob Chemother 62: 431-433 [Abstract] [Full text]  
• Harbarth, S., Pittet, D. (2008). Universal Screening for Methicillin-Resistant Staphylococcus aureus by Hospitals--Reply. JAMA 300: 504-505 [Full text]  
• Melzer, M., Bain, L., Drabu, Y. J (2008). Preventing infections from cannulas reduces MRSA. BMJ 336: 1085-1086 [Full text]  
• (2008). Screening for MRSA Using PCR. JWatch General 2008: 1-1 [Full text]  
• Wilcox, M. H (2008). Screening for MRSA. BMJ 336: 899-900 [Full text]  

Rapid Responses:

Read all Rapid Responses

Preventing infections caused by intravascular devices reduces MRSA bacteraemia rates

Mark Melzer, et al.
bmj.com, 1 May 2008 [Full text]

Rapid MRSA tests do not prevent acquisition of MRSA during hospital stay.

Ed J. Kuijper
bmj.com, 6 May 2008 [Full text]